These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18195273)

  • 1. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
    Brenner SR
    Neurology; 2008 Jan; 70(3):243-4. PubMed ID: 18195273
    [No Abstract]   [Full Text] [Related]  

  • 2. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.
    Kalaria RN
    Neurobiol Aging; 2009 Sep; 30(9):1512-4. PubMed ID: 18187235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.
    Price JM; Chi X; Hellermann G; Sutton ET
    Neurol Res; 2001 Jul; 23(5):506-12. PubMed ID: 11474807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the white matter matter in Alzheimer disease and cerebral amyloid angiopathy?
    Lee JM; Markus HS
    Neurology; 2006 Jan; 66(1):6-7. PubMed ID: 16401835
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of vascular risk to the progression of Alzheimer disease.
    Borroni B; Archetti S; Ferrari M; Cesana BM; Padovani A
    Neurology; 2007 Mar; 68(13):1083-4; author reply 1084. PubMed ID: 17389321
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
    Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
    Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease.
    Kitaguchi H; Ihara M; Saiki H; Takahashi R; Tomimoto H
    Neurosci Lett; 2007 May; 417(2):128-31. PubMed ID: 17403574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice.
    Araya R; Noguchi T; Yuhki M; Kitamura N; Higuchi M; Saido TC; Seki K; Itohara S; Kawano M; Tanemura K; Takashima A; Yamada K; Kondoh Y; Kanno I; Wess J; Yamada M
    Neurobiol Dis; 2006 Nov; 24(2):334-44. PubMed ID: 16956767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias.
    Togo T; Katsuse O; Iseki E
    Neurol Res; 2004 Jul; 26(5):563-6. PubMed ID: 15265275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
    Benarroch EE
    Neurology; 2007 May; 68(20):1730-2. PubMed ID: 17502556
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer's disease and Abeta toxicity: from top to bottom.
    Small DH; Mok SS; Bornstein JC
    Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebrovascular circulation and cerebral metabolism in aging].
    Gottstein U
    Internist (Berl); 1984 Aug; 25(8):470-7. PubMed ID: 6384112
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.
    Kisler K; Nelson AR; Montagne A; Zlokovic BV
    Nat Rev Neurosci; 2017 Jul; 18(7):419-434. PubMed ID: 28515434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A link between sICAM-1, ACE and parietal blood flow in the aging brain.
    Janciauskiene SM; Erikson C; Warkentin S
    Neurobiol Aging; 2009 Sep; 30(9):1504-11. PubMed ID: 18243419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.
    Coulson EJ; May LM; Sykes AM; Hamlin AS
    Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid and glutamate receptors.
    Gasparini L; Dityatev A
    Exp Neurol; 2008 Jul; 212(1):1-4. PubMed ID: 18448101
    [No Abstract]   [Full Text] [Related]  

  • 18. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?
    Aliyev A; Seyidova D; Rzayev N; Obrenovich ME; Lamb BT; Chen SG; Smith MA; Perry G; de la Torre JC; Aliev G
    Neurol Res; 2004 Jul; 26(5):547-53. PubMed ID: 15265272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic regulation of the fetal cerebral circulation.
    Pearce W
    J Appl Physiol (1985); 2006 Feb; 100(2):731-8. PubMed ID: 16421280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does acidosis in brain play a role in Alzheimer's disease?].
    Pirchl M; Humpel C
    Neuropsychiatr; 2009; 23(3):187-92. PubMed ID: 19703385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.